The Aperio Blog
Aperio Receives Medidata Rave Coder Accreditation
October 25, 2018
Aperio is committed to offering our pharmaceutical, biotechnology and device clients expertise in state-of-the-art technology that optimizes the clinical research process and gets drugs to market faster for patients in need.
A Medidata Partner since 2017, Aperio announced earlier this year that they have been expanding their use of the Medidata Clinical Cloud® platform to help support all aspects of clinical research from study planning to study close. In keeping with the expansion, Aperio is now pleased to announce that they have received full accreditation to provide medical coding services using Medidata’s leading cloud-based medical coding application, Medidata Rave Coder.
Aperio has already received full accreditation to provide electronic data capture services for clinical trials using Medidata Rave EDC. Aperio is working on accreditation in several of Medidata’s other best-in-class clinical trial cloud technologies.
Transparency with our clients is one of Aperio’s most important differentiators. By providing a single source of truth, the Medidata platform allows Aperio to live out this core value with our clients every day.
About Aperio Clinical Outcomes
Aperio Clinical Outcomes provides full, customizable clinical research services across multiple therapeutic areas. Dedicated to transparent interactions with clients, Aperio also offers consulting services in Quality Assurance, Strategic Resourcing, and practical application of the latest Clinical Trial Technology.
In an industry flooded with data, metrics and technology, Aperio remains steadfastly focused on the most important part of the process: people. From start-up to close out and every point in between, Aperio works with its partners to deliver outcomes that will improve patient care and save lives.
Aperio Clinical Outcomes.
We make it clear.
